Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy

Oncotarget. 2016 Aug 30;7(35):57391-57413. doi: 10.18632/oncotarget.10548.

Abstract

While the mechanisms underlying apoptosis and autophagy have been well characterized over recent decades, another regulated cell death event, necroptosis, remains poorly understood. Elucidating the signaling networks involved in the regulation of necroptosis may allow this form of regulated cell death to be exploited for diagnosis and treatment of cancer, and will contribute to the understanding of the complex tumor microenvironment. In this review, we have summarized the mechanisms and regulation of necroptosis, the converging and diverging features of necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy, as well as attempts to exploit this newly gained knowledge to provide therapeutics for cancer.

Keywords: anti-tumor immune; cancer therapy; necroptosis; tumorigenesis.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Apoptosis*
  • Autophagy
  • Biomarkers, Tumor
  • Carcinogenesis
  • Cell Death
  • Cell Transformation, Neoplastic / metabolism
  • Cytokines / metabolism
  • Humans
  • Immune System
  • Necrosis / pathology*
  • Neoplasms / immunology*
  • Neoplasms / pathology*
  • Radiotherapy
  • Receptor-Interacting Protein Serine-Threonine Kinases / metabolism
  • Signal Transduction
  • T-Lymphocytes / cytology
  • Tumor Microenvironment
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Cytokines
  • Tumor Necrosis Factor-alpha
  • Receptor-Interacting Protein Serine-Threonine Kinases